Brief: Dice Therapeutics Reports Q4 And Full Year 2022 Financial Results And Recent Highlights
March 15 (Reuters) - Dice Therapeutics Inc DICE.O :
* DICE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND RECENT HIGHLIGHTS
* ENDED 2022 WITH $574.2 MILLION IN CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES, PROVIDING RUNWAY INTO 2026
* QTRLY LOSS PER SHARE $0.51
* Q4 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX97dgFc
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources